1 THC GLOBAL GROUP LIMITED (ASX:THC)

Smart thinking on cannabis

THC Global Group Limited (ASX:THC)

Investor PresentationJune 2020

22 THC GLOBAL GROUP LIMITED (ASX:THC)

Australia’s newest pharmaceutical company - delivered

Launched Affordable Medicines Range

Acquired Clinics to Increase Accessibility

Established Export Channels

Achieved Dominant Market Position

Positioned to Lead Pharma OTC

Own Australian Bio-Pharma Factory

Complete GMP Certification (EU and TGA)

Launched Global Scale Medicines Supply

Secured Upstream Cannabis Supply

33 THC GLOBAL GROUP LIMITED (ASX:THC)

Delivering in Four Core AreasGlobal Supply of

Medicines

Direct Patient Healthcare Services

Global Supply of Medicines

Direct Patient Healthcare Services

World Class Pharma Production

Four interconnected revenue centres addressing major global barriers to industry growth

Turnkey Cultivation Solutions

44 THC GLOBAL GROUP LIMITED (ASX:THC)

Pharma Production Made World ClassScalable Production

Production capacity scalable up to 1 million patients per annum with limited additional capex.

TGA & EU GMP Licenced

Pharma GMP cannabis medicines production with full EU compliance enabling export opportunities.

Reliable Supply Secured

Access to own cultivation facilities in addition to local Aust growers, and crude extract imports.

Onsite R&D Lab

Onsite labs enables product testing and validation in addition to production required for clinical trials.

Finished Goods Diversity

Developing capability for production of capsules, tablets, creams and other finished product forms.

White Label & Own Lines

Ability to service high volume bulk processing or white-labelled orders without limiting own production.

55 THC GLOBAL GROUP LIMITED (ASX:THC)

Pharma Production at Global Scale

Third Party Brands

Canndeo Branded Medicines

Pharmaceutical API

Third Party Australian Growers

THC Global Cultivation Sites

International Raw Crude

66 THC GLOBAL GROUP LIMITED (ASX:THC)

Affordable and Accessible Medicines

Canndeo

77 THC GLOBAL GROUP LIMITED (ASX:THC)

Opening Australia’s Prescribing MarketPrescribing MarketPrescribing Market

Tetra Health

THC GLOBAL GROUP LIMITED (ASX:THC)

CanndeoCare

0

1000

2000

3000

4000

5000

6000

7000

8000

9000

10000

Apr-

19

May

-19

Jun-

19

Jul-1

9

Aug-

19

Sep-

19

Oct

-19

Nov

-19

Dec

-19

Jan-

20

Feb-

20

Mar

-20

Apr-

20

SAS-B Approvals

Solving theAffordability &

Accessibility Gap

88 THC GLOBAL GROUP LIMITED (ASX:THC)

Capturing theNew Pharma OTC MarketUnprecedented opportunity to dominate a new $200m+ market

$200m+ Addressable Patient Market

Order of Magnitude Volume Increase

White Label Opportunity

Canndeo Branded Medicines

THC GLOBAL GROUP LIMITED (ASX:THC)

99 THC GLOBAL GROUP LIMITED (ASX:THC)

Exporting to Global Markets

Delivering a global supply of affordable quality medicines 2020

2021+

1010 THC GLOBAL GROUP LIMITED (ASX:THC)

Smart Businesses for the Canadian MarketCanadian MarketCanadian Market

Turnkey Cultivation Solutions

THC GLOBAL GROUP LIMITED (ASX:THC)

Solutions

Medicinal Cannabis

High growth businesses developed for the Canadian market with strong profitability potential

1111 THC GLOBAL GROUP LIMITED (ASX:THC)

Laura Harvey Angela Maguire Diandra Phipps Sonny Didugu

Steven Xu Ken Charteris Jarrod White Andrew BeehagSteven Xu Ken Charteris Jarrod WhiteJarrod White Andrew BeehagBeehag

Sonny Didugu Sonny Didugu

Global Management Team

Diandra PhippsDiandra PhippsLaura HarveyLaura Harvey Angela MaguireAngela Maguire

1212 THC GLOBAL GROUP LIMITED (ASX:THC)

Capital and Financial OverviewKey Information

ASX Code ASX:THC

Listing Date May 2017

GICS Classification Pharmaceuticals, Biotechnology & Life Science

Share Price(3 June)

$0.44

Market Cap(3 June)

$64.25 million

Shares on Issue(3 June)

146,028,486

Shareholders(3 June)

8,888 Shareholders

Recent Financials

Cash(31 March)

$2.26 million + $4m debt facility

Property Plant and Equipment (2019)

$18.4 million

Existing Debt $4 million secured debt facility repayable 31 October 2021

2019 Group Revenue $4.79 million

Revenue Growth 55% YoY (2018-19)44% YoY on Q1 Cash Receipts

1313 THC GLOBAL GROUP LIMITED (ASX:THC)

Disclaimer

1414 THC GLOBAL GROUP LIMITED (ASX:THC)

CONTACT THC GLOBAL GROUPASX:THC

W E Bthc.global

C O R P O R A T E O F F I C ESuite 4102

Level 41 Austral ia Square

264-278 George Street

Sydney NSW 2000

Austral ia

E M A I Lcorporate@thc.global